Measuring Success: Navigating the Top 3 Clinical Outcome Assessments in Alopecia Areata
Alopecia areata (AA) is a multifaceted condition that presents unique challenges for both clinicians and patients. The precise evaluation of treatment results is pivotal in ascertaining the process of various therapeutic strategies. This article explores 3 key clinical outcome assessments (COAs) used in AA: the Severity of Alopecia Tool (SALT), the AA Investigator Global Assessment […]
A Success Story: Pre-IND and IND Support for an Alopecia Areata Investigational Product
Click here for a PDF version of this case study Steps and Actions Taken Pre-IND Submission Clinical Section Development: Preparation of clinical sections of the pre-IND and provide clinical trial design suggestions. Synopsis Writing: Drafted the synopsis for their first clinical study. Pre-Clinical Data Review: Conducted a quick review of toxicology and pre-clinical data to […]
The Intricacies of Multicenter Studies in Alopecia Areata
Alopecia Areata: The Condition Alopecia Areata (AA)Â is a medical condition characterized by hair loss that occurs in patches on the scalp or other parts of the body. The hair loss is not uniform and can vary greatly from patient to patient, with some experiencing minimal hair loss and others losing hair across their entire scalp […]
Atopy and Alopecia Areata: A Leading Pair
Alopecia areata (AA) and atopy, which is a predisposition to develop allergic reactions, share a significant connection. While thyroid complications are often the primary concern in autoimmune diseases, a substantial number of these patients also suffer from allergies and hypersensitivities. In fact, atopic conditions are found in 30% to 50% of AA patients. Importance of Understanding Atopy […]
“Working with Indero for our alopecia areata trial has been a smooth and exceptional experience (…)â – An Inmagene Biopharmaceuticals Testimonial
Our remarkable team has received high praise from yet another satisfied customer! “Working with Innovaderm for our alopecia areata trial has been a smooth and exceptional experience, marked by their extensive expertise, proactive approach, and seamless collaboration.” Duong Nguyen, Head of Clinical Operations at Inmagene Biopharmaceuticals. âInnovadermâs profound understanding of alopecia areata and their forward-thinking strategy […]
Dr. Robert Bissonnette and Dr. Kim Papp on Alopecia Areata Insights
In collaboration with Probity Medical Research (PMR) Dr.âŻRobert Bissonnette from Innovaderm Research and Dr.âŻKim Papp from Probity Medical Research (PMR) met at the 2023 EADV for an engaging conversation focused on the intricacies of early phase studies and explored the significant challenges of conducting vitiligo studies. In this article, we shift the focus on alopecia areata (AA) studies insights, exploring the […]
Safety of baricitinib in patients with alopecia areata
Date: 2023-10-02 Authors: Bissonnette R Category: Other Conflict of interest statement: Conflicts of interest The full list is provided in Appendix S1 (see Supporting Information). Read more on pubmed
Alopecia Areata (AA) Case Study
Click here for a PDF version of this case study Outcomes Innovadermâs outstanding support on this alopecia areata study resulted in a rapid increase in enrollment rates and the successful management of this trial Study Characteristics Study Phase: II Patient Population: Alopecia Areata IP Route of Administration: Systemic Sites distribution: 12 sites (CAD-USA) Complex study procedures: […]
